July 2023

11 Jul celares GmbH Sells to Biosynth

BroadOak Capital Partners advised Biosynth on the acquisition of celares GmbH.  Celares provides customized bioconjugation solutions for Pharma and IVD industries. The full press release is below. Staad, 11th July 2023 – Biosynth, a supplier of critical raw materials to the life science industry, is pleased to announce...